Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,039 | 2,355 | -1,830 | 2,370 | 3,812 |
| Depreciation Amortization | 4,659 | 3,939 | 4,035 | 4,258 | 4,418 |
| Income taxes - deferred | 15,116 | 1,412 | -2,441 | -731 | -849 |
| Accounts receivable | -1,340 | -735 | 436 | 1,154 | 232 |
| Accounts payable and accrued liabilities | 2,577 | 1,069 | -41 | -905 | 69 |
| Other Working Capital | -2,719 | -4,514 | 1,940 | 256 | -3,854 |
| Other Operating Activity | 1,451 | 825 | 1,961 | 1,660 | 2,820 |
| Operating Cash Flow | $705 | $4,351 | $4,060 | $8,062 | $6,648 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,954 | -864 | -1,556 | -1,736 | -1,481 |
| Net Acquisitions | -4,545 | -12,653 | 1,784 | -2,878 | -5,465 |
| Other Investing Activity | -18 | 0 | -57 | -62 | -252 |
| Investing Cash Flow | $-7,517 | $-13,517 | $171 | $-4,676 | $-7,198 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,800 | 2,200 | 14,550 | 500 | N/A |
| Debt Repayment | -8,350 | -5,500 | N/A | -3,850 | -1,708 |
| Common Stock Issued | 2,042 | 2,066 | 3,621 | 2,287 | 567 |
| Other Financing Activity | -32 | 0 | -18,103 | 0 | 0 |
| Financing Cash Flow | $-540 | $-1,234 | $68 | $-1,063 | $-1,141 |
| Exchange Rate Effect | -38 | -1,237 | 791 | 442 | -97 |
| Beginning Cash Position | 14,134 | 25,771 | 20,681 | 17,916 | 19,704 |
| End Cash Position | 6,744 | 14,134 | 25,771 | 20,681 | 17,916 |
| Net Cash Flow | $-7,390 | $-11,637 | $5,090 | $2,765 | $-1,788 |
| Free Cash Flow | |||||
| Operating Cash Flow | 705 | 4,351 | 4,060 | 8,062 | 6,648 |
| Capital Expenditure | -2,960 | -2,005 | -1,622 | -1,769 | -1,506 |
| Free Cash Flow | -2,255 | 2,346 | 2,438 | 6,293 | 5,142 |